GNH USA

Europe — EMA

Influvac

GNH USA supplies Influvac (influenza virus vaccine), a vaccine for prevention of influenza A and B infections. Request a quote for global supply today.

Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26), Influenza A/Vic

Request sourcing

1
Pack/s

What is Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26), Influenza A/Vic?

influenza virus vaccine, the active ingredient in Influvac, is a vaccine presented as an injectable solution for intramuscular or subcutaneous use. It prevents influenza infection caused by influenza A and B viruses in individuals at risk.

GNH USA supplies Influvac as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26), Influenza A/Vic used for?

Influvac is a vaccine that targets the influenza virus family to provide active immunization against seasonal flu. - Seasonal influenza (influenza A and B): provides active immunization to reduce the incidence of flu illness. - High‑risk populations (elderly, chronic disease patients): lowers the risk of severe influenza complications. - Community health programs: contributes to herd immunity and reduces overall flu transmission.

What are the side effects of Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26), Influenza A/Vic?

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Redness or swelling: localized erythema or edema. - Low‑grade fever: transient temperature rise. - Headache: mild headache within 24 hours. - Myalgia: muscle aches. - Fatigue: temporary tiredness.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical care. - Guillain‑Barré syndrome: rare neurological disorder. - Severe allergic reaction: urticaria, angioedema, or respiratory distress. - High fever: temperature >39 °C persisting beyond 48 hours. - Seizures: uncommon neurologic event. - Myocarditis: rare inflammation of heart muscle.

What precautions apply to Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26), Influenza A/Vic?

Before administration, consider the following precautions: - Severe allergy: avoid if the patient has a known hypersensitivity to any vaccine component. - Acute illness: postpone vaccination in individuals with moderate or severe febrile illness. - Prior Guillain‑Barré syndrome: evaluate risk‑benefit before use. - Pregnancy and lactation: administer only if potential benefits outweigh theoretical risks. - Immunocompromised patients: vaccine may be less effective; monitor response. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

What does Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26), Influenza A/Vic interact with?

Vaccines can interact with other agents that affect immune response. Major Interactions (Avoid): - Immunoglobulin therapy: may diminish vaccine‑induced immunity. - Live viral vaccines: avoid simultaneous administration due to potential interference. Moderate Interactions (Monitor Closely): - Antipyretics (acetaminophen, ibuprofen): prophylactic use may reduce antibody response. - Immunosuppressive therapy: may lower vaccine efficacy. - Corticosteroids: may affect immune response to the vaccine.

Frequently asked questions

What is Influvac used for?+
Influvac is a seasonal influenza vaccine indicated for active immunization against influenza A and B viruses, helping to prevent flu illness in both adults and children when administered according to public health guidelines.
How does the influenza virus vaccine work?+
The vaccine contains purified viral antigens that stimulate the immune system to produce antibodies against hemagglutinin and neuraminidase proteins, establishing active immunity that can neutralize the influenza virus upon future exposure.
What is the usual dose of Influvac?+
The prescribed dose is determined by the treating healthcare professional based on the patient’s age, health status, and local immunization recommendations, and is delivered as a single intramuscular or subcutaneous injection.
Is Influvac safe during pregnancy or breastfeeding?+
Safety data are limited; the vaccine may be administered during pregnancy or lactation only when the potential benefits to the mother and fetus outweigh any theoretical risks, and the decision should be made by a qualified clinician.
How do I order Influvac from GNH USA?+
Submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details and necessary import documentation.
How does Influvac compare with other influenza vaccines?+
Influvac contains the WHO‑recommended strains similar to other licensed quadrivalent or trivalent vaccines. Formulation differences such as split‑virus versus subunit may affect reactogenicity, but overall efficacy is comparable when administered according to recommended schedules.
How should Influvac be stored and handled?+
Store the vaccine at 2‑8 °C in a refrigerator, protect it from light, and never freeze or shake the vial. Keep it in the original packaging until use to maintain potency and stability.
How is Influvac administered?+
A qualified healthcare professional injects Influvac intramuscularly, typically into the deltoid muscle, or subcutaneously if indicated, using a sterile needle and syringe following standard aseptic technique.
What are the most serious risks associated with Influvac?+
Rare but serious adverse events include anaphylaxis, severe allergic reactions, and Guillain‑Barré syndrome. Patients should be observed after vaccination and seek immediate medical attention if they experience breathing difficulty, swelling, or neurological changes.
Who should not receive Influvac?+
Individuals with a known severe allergy to any vaccine component, those who have experienced a previous severe reaction to an influenza vaccine, or persons with a history of Guillain‑Barré syndrome following a prior influenza vaccination should avoid Influvac unless specifically advised by a clinician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26), Influenza A/Vic
Route
Intramuscular Use , Subcutaneous Use
Manufacturer
Viatris Healthcare Limited
Origin
EU

Related products